|1.||Farncombe, Troy H: 1 article (07/2011)|
|2.||Gleave, Jacqueline A: 1 article (07/2011)|
|3.||Doering, Laurie C: 1 article (07/2011)|
|4.||Saab, Chantal: 1 article (07/2011)|
|5.||Cattabeni, Flaminio: 1 article (11/2002)|
|6.||Fischman, A J: 1 article (11/2001)|
|7.||Friedman, J H: 1 article (11/2001)|
|8.||Fernandez, H H: 1 article (11/2001)|
|9.||Noto, R B: 1 article (11/2001)|
|10.||Lannon, M C: 1 article (11/2001)|
|1.||Parkinson Disease (Parkinson's Disease)
11/01/2001 - "Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease?"
10/20/2000 - "Altropane, 2beta-carbomethoxy-3beta-(4-fluorophenyl)-N-(3-iodo-E-allyl)nor tropane, is an imaging agent that was developed recently for early detection of Parkinson's disease. "
07/01/1996 - "IACFT could prove to be extremely useful for the noninvasive evaluation of patients with early Parkinson's disease."
11/01/2002 - "Boston Life Sciences (BLS) is developing Altropane as a potential radio-imaging agent to be used with single photon emission tomography (SPECT), for the early diagnosis of Parkinson's disease (PD) and attention deficit hyperactivity disorder (ADHD) . "
06/01/1998 - "In this study, single photon emission computed tomography (SPECT) with [123I]altropane was used to measure DAT density in seven healthy volunteers (five males, age 37-75, and two females, ages 26 and 39) and eight male patients with Parkinson's disease (age 14-79, Hoehn and Yahr stage: 1.5-3 (n = 5) and 4-5 (n = 3)). "
|2.||Parkinsonian Disorders (Parkinsonism)
|3.||Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
|1.||Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
|2.||Oxidopamine (6 Hydroxydopamine)
|3.||tranilast (N 5')
|4.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)